Keywords: Bristol-Myers, Pfizer, Eliquis, Pristiq, Stroke prevention, Menopause, USA, FDA

US FDA delays Eliquis decision; Pristiq dropped for menopause

Article | 02 March 2012

Print This

USA drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) say that the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in